鼻内雾化右美托咪定联合鼻内雾化布托啡诺用于成人烧伤患者换药镇静镇痛:一项随机临床试验
研究纳入46例成人烧伤换药患者,随机分为右美托咪定-布托啡诺组(DB组)与生理盐水-布托啡诺组,比较鼻内雾化给药后的镇静镇痛效果。DB组换药期间RSS评分显著更低,VAS评分各时点两组无显著差异;DB组操作开始时、操作后10分钟及20分钟MBP降低,操作开始时及操作后10分钟心率降低,RR与SpO2无显著差异;DB组补救布托啡诺剂量更低,头晕和恶心发生率显著更低。作者结论认为,除血流动力学不良反应外,IAD+IAB联合治疗的镇静效果优于单用IAB。
要点
- DB组换药期间RSS评分显著低于生理盐水-布托啡诺组(P < .05)。
- 两组VAS评分在所有测量时点均无显著差异。
- DB组补救布托啡诺剂量更低(P < .001),头晕和恶心发生率显著更低(P < .05)。
核心结论
- 除血流动力学不良反应外,鼻内雾化右美托咪定联合鼻内雾化布托啡诺在成人烧伤患者中比单用鼻内雾化布托啡诺产生更好的镇静效果。
研究设计与样本
- 随机临床试验,纳入46例接受换药的成人烧伤患者,随机分为右美托咪定-布托啡诺组(DB组)和生理盐水-布托啡诺组,分别接受鼻内雾化右美托咪定+布托啡诺和生理盐水+布托啡诺治疗。
主要发现
- 两组年龄、性别、体重和总烧伤体表面积具有可比性。
- 换药期间DB组RSS水平显著更低(P < .05)。
- 两组VAS评分在所有测量时点均无显著差异。
- DB组平均动脉压在操作开始时(P < .0001)、操作后10分钟(P < .0001)和操作后20分钟(P = .0205)降低;心率在操作开始时(P = .0005)和操作后10分钟(P = .0088)显著降低。
- 两组呼吸频率和SpO2水平无显著差异;DB组补救布托啡诺剂量更低(P < .001),头晕和恶心发生率显著更低(P < .05)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We aimed to evaluate the efficacy of the intranasal atomized dexmedetomidine (IAD) + intranasal atomized butorphanol (IAB) combination therapy on adult patients with burns undergoing dressing changes. Herein, 46 adult patients with burns were enrolled and randomly divided into 2 groups: dexmedetomidine-butorphanol (DB) and saline-butorphanol, treated with atomized dexmedetomidine + butorphanol and saline + butorphanol, respectively. The primary outcomes were the Ramsay Sedation Scale (RSS) and the Visual Analog Scale (VAS) scores. The secondary outcomes were mean blood pressure (MBP), heart rate, respiratory rate (RR), peripheral blood oxygen saturation (SpO2), total butorphanol consumption, and adverse effects. The 2 groups were comparable in age, sex, weight, and total burn surface area. During dressing changes, the DB group exhibited significantly lower RSS levels (P < .05). Besides, the 2 groups showed no significant differences in VAS scores across all measurement time points. Notably, the DB group exhibited decreased MBP at the beginning of the operation (P < .0001), 10 min after (P < .0001), and 20 min after (P = .0205). Heart rate decreased significantly at the beginning (P = .0005) and 10 min after (P = .0088) in the DB group. Furthermore, the 2 groups showed no significant differences in RR and SpO2 levels. In addition, the rescue butorphanol dose was lower in the DB group (P < .001). Finally, dizziness and nausea incidences were significantly lower in the DB group (P < .05). In conclusion, besides its hemodynamic adverse reactions, the IAD + IAB combination therapy exerted a better sedation effect in adult patients with burns than IAB treatment alone.
引用
- Ding X, Shi D, Cai H, et al. Intranasal Atomized Dexmedetomidine in Combination With Intranasal Atomized Butorphanol for Dressing Change Sedation and Analgesia in Adult Burn Patients: A Randomized Clinical Trial. J Burn Care Res. 2025. PMID: 39126665. doi:10.1093/jbcr/irae158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。